Achieve Life Sciences, Inc. (ACHV) Stock Ticker
ACHV right now
Market factors today
Unlock the full ACHV picture
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.
ACHV stock facts
| Ticker symbol | ACHV |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $774.0M |
| CEO | Andrew D. Goldberg |
| Employees | 28 |
| Headquarters | Bothell, WA, US |
| IPO date | 1995-10-12 |
| Website | www.achievelifesciences.com |
What you can see for ACHV on Tickr
Live ACHV price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ACHV report.
Rankings
FAQ
What is the ticker symbol for Achieve Life Sciences, Inc.?
The ticker symbol for Achieve Life Sciences, Inc. is ACHV, listed on the NASDAQ Capital Market.
What is ACHV?
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by…